Yuexin Xu
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Pharmacology top 10%
-
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 4
-
- Bone Metabolism and Diseases 6
- Renal and related cancers 3
- Single-cell and spatial transcriptomics 2
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Yucui JinChangyan MaChang LiuZhimin YinJingwen ChenXiao YuWeiwei TaoJiang Fengrong
- Cited by
- Cancer ResearchPharmacologyOncology
- Journals
- Journal of Cellular and Molecular Medicine (3 papers)Frontiers in Cell and Developmental Biology (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesSouth Africa
In The Last Decade
Yuexin Xu
28 papers receiving 548 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 97
- Pharmacology 54
- Oncology 131
- Molecular Biology 303
- Immunology 75
Countries citing papers authored by Yuexin Xu
This map shows the geographic impact of Yuexin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuexin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuexin Xu more than expected).
Fields of papers citing papers by Yuexin Xu
This network shows the impact of papers produced by Yuexin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuexin Xu. The network helps show where Yuexin Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuexin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 14 | |
| 14 | 2019 | 36 | |
| 15 | 2019 | 20 | |
| 16 | 2017 | 44 | |
| 17 | 2016 | 31 | |
| 18 | 2015 | 10 | |
| 19 | 2014 | 88 | |
| 20 | 2010 | 100 |
About Yuexin Xu
Yuexin Xu is a scholar working on Cancer Research, Oncology and Immunology, having authored 31 papers that have together received 556 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Bone Metabolism and Diseases (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), MicroRNA in disease regulation (3 papers), Renal and related cancers (3 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Cancer Research (97 citations), Pharmacology (54 citations) and Oncology (131 citations). Yuexin Xu has collaborated with scholars based in China, United States and South Africa. Frequent co-authors include Yucui Jin, Changyan Ma, Chang Liu, Zhimin Yin, Jingwen Chen, Xiao Yu, Weiwei Tao, Jiang Fengrong, Bing Yao and Edus H. Warren. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Frontiers in Cell and Developmental Biology, Oncotarget, Inflammation Research and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.